Literature DB >> 14568938

Estimating hypermutation rates from clonal tree data.

Steven H Kleinstein1, Yoram Louzoun, Mark J Shlomchik.   

Abstract

To understand the mechanisms underlying the varying patterns of mutations that occur during immune and autoimmune responses, estimates of the somatic hypermutation rate are critical. However, despite its significance, precise estimates of the mutation rate do not currently exist. Microdissection studies of mutating B cell clones provide an opportunity to measure this rate more accurately than previously possible. Each microdissection provides a number of clonally related sequences that, through the analysis of shared mutations, can be genealogically related to each other. The shape of these clonal trees is influenced by many processes, including the hypermutation rate. We have developed two different methods to estimate the mutation rate based on these data. These methods are applied to two sets of experimental data, one from an autoimmune response and one from the antihapten response to (4-hydroxy-3-nitrophenyl)acetyl (NP). Comparable mutation rates are estimated for both responses, 0.7-0.9 x 10(-3) and 0.9-1.1 x 10(-3) bp(-1) division(-1) for the autoimmune and NP responses, respectively. In addition to comparing the results of the two procedures, we investigate the effect on our estimate of assumptions, such as the fraction of lethal mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568938     DOI: 10.4049/jimmunol.171.9.4639

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.

Authors:  Anthony Chang; Scott G Henderson; Daniel Brandt; Ni Liu; Riteesha Guttikonda; Christine Hsieh; Natasha Kaverina; Tammy O Utset; Shane M Meehan; Richard J Quigg; Eric Meffre; Marcus R Clark
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

2.  Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation.

Authors:  Uri Hershberg; Mark J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

3.  Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification.

Authors:  Alicia D Volkheimer; J Brice Weinberg; Bethany E Beasley; John F Whitesides; Jon P Gockerman; Joseph O Moore; Garnett Kelsoe; Barbara K Goodman; Marc C Levesque
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

4.  T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.

Authors:  Robin A Herlands; Sean R Christensen; Rebecca A Sweet; Uri Hershberg; Mark J Shlomchik
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

5.  Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data.

Authors:  Namita T Gupta; Jason A Vander Heiden; Mohamed Uduman; Daniel Gadala-Maria; Gur Yaari; Steven H Kleinstein
Journal:  Bioinformatics       Date:  2015-06-10       Impact factor: 6.937

6.  The mutation patterns in B-cell immunoglobulin receptors reflect the influence of selection acting at multiple time-scales.

Authors:  Gur Yaari; Jennifer I C Benichou; Jason A Vander Heiden; Steven H Kleinstein; Yoram Louzoun
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

7.  Salmonella Infection Drives Promiscuous B Cell Activation Followed by Extrafollicular Affinity Maturation.

Authors:  Roberto Di Niro; Seung-Joo Lee; Jason A Vander Heiden; Rebecca A Elsner; Nikita Trivedi; Jason M Bannock; Namita T Gupta; Steven H Kleinstein; Francois Vigneault; Tamara J Gilbert; Eric Meffre; Stephen J McSorley; Mark J Shlomchik
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

8.  Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.

Authors:  Robin A Herlands; Jacqueline William; Uri Hershberg; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

Review 9.  T-cell receptor profiling in cancer.

Authors:  Ilan Kirsch; Marissa Vignali; Harlan Robins
Journal:  Mol Oncol       Date:  2015-09-15       Impact factor: 6.603

10.  Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease.

Authors:  Manoj Thapa; Dana Tedesco; Sanjeev Gumber; Elizabeth J Elrod; Jin-Hwan Han; William H Kitchens; Joseph F Magliocca; Andrew B Adams; Arash Grakoui
Journal:  J Immunol       Date:  2020-04-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.